Notably compound XY‐14, reported to competitively inhibit lipid phosphate phosphatase,[32] effectively restrained RCC cell proliferation and migration (Figure 4L–N; Figure S3N–P, Supporting Information). The gene discussed is EPHX2; the disease is renal cell carcinoma.